About Anbio Biotechnology
Sector
Industry
Headquarters
Frankfurt
Website
Founded
2021
FIGI
BBG01RL0JPJ9
Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NNNN is 5.67 USD — it has decreased by −1.73% in the past 24 hours. Watch Anbio Biotechnology stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Anbio Biotechnology stocks are traded under the ticker NNNN.
NNNN stock has risen by 7.79% compared to the previous week, the month change is a 7.79% rise, over the last year Anbio Biotechnology has showed a 7.79% increase.
No, NNNN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NNNN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Anbio Biotechnology stock right from TradingView charts — choose your broker and connect to your account.